Heterocyclic Compounds: Pharmacology of Pyrazole Analogs From Rational Structural Considerations

Low quality of life and life-threatening conditions often demand pharmacological screening of lead compounds. A spectrum of pharmacological activities has been attributed to pyrazole analogs. The substitution, replacement, or removal of functional groups on a pyrazole ring appears consistent with diverse molecular interactions, efficacy, and potency of these analogs. This mini-review explores cytotoxic, cytoprotective, antinociceptive, anti-inflammatory, and antidepressant activities of some pyrazole analogs to advance structure-related pharmacological profiles and rational design of new analogs. Numerous interactions of these derivatives at their targets could impact future research considerations and prospects while offering opportunities for optimizing therapeutic activity with fewer adverse effects.

Citing Articles

Therapeutic Role of Heterocyclic Compounds in Neurodegenerative Diseases: Insights from Alzheimer's and Parkinson's Diseases.

Puranik N, Song M Neurol Int. 2025; 17(2).

PMID: 39997657 PMC: 11858632. DOI: 10.3390/neurolint17020026.

Recent highlights in the synthesis and biological significance of pyrazole derivatives.

Moussa Z, Ramanathan M, Alharmoozi S, Alkaabi S, Al Aryani S, Ahmed S Heliyon. 2024; 10(20):e38894.

PMID: 39492900 PMC: 11531639. DOI: 10.1016/j.heliyon.2024.e38894.

Marine-derived magnetic nanocatalyst in sustainable ultrasound-assisted synthesis of 2,3-diphenyl-2,3-Dihydroquinazolin-4(1H)-One derivatives.

Buazar F, Sayahi M Heliyon. 2024; 10(19):e38948.

PMID: 39435118 PMC: 11492587. DOI: 10.1016/j.heliyon.2024.e38948.

Structure-Activity Relationship Studies on Highly Functionalized Pyrazole Hydrazones and Amides as Antiproliferative and Antioxidant Agents.

Lusardi M, Signorello M, Russo E, Caviglia D, Ponassi M, Iervasi E Int J Mol Sci. 2024; 25(9).

PMID: 38731825 PMC: 11083148. DOI: 10.3390/ijms25094607.

Highly efficient, catalyst-free, one-pot sequential four-component synthesis of novel spiroindolinone-pyrazole scaffolds as anti-Alzheimer agents: study and biological screening.

Pourtaher H, Mohammadi Y, Hasaninejad A, Iraji A RSC Med Chem. 2024; 15(1):207-222.

PMID: 38283217 PMC: 10809384. DOI: 10.1039/d3md00255a.

References

Toton E, Ignatowicz E, Bernard M, Kujawski J, Rybczynska M . Evaluation of apoptotic activity of new condensed pyrazole derivatives. J Physiol Pharmacol. 2013; 64(1):115-23. View

Murahari M, Mahajan V, Neeladri S, Kumar M, Mayur Y . Ligand based design and synthesis of pyrazole based derivatives as selective COX-2 inhibitors. Bioorg Chem. 2019; 86:583-597. DOI: 10.1016/j.bioorg.2019.02.031. View

Kamel M . Convenient synthesis, characterization, cytotoxicity and toxicity of pyrazole derivatives. Acta Chim Slov. 2015; 62(1):136-51. DOI: 10.17344/acsi.2014.828. View

Clemett D, Goa K . Celecoxib: a review of its use in osteoarthritis, rheumatoid arthritis and acute pain. Drugs. 2000; 59(4):957-80. DOI: 10.2165/00003495-200059040-00017. View

Baral P, Udit S, Chiu I . Pain and immunity: implications for host defence. Nat Rev Immunol. 2019; 19(7):433-447. PMC: 6700742. DOI: 10.1038/s41577-019-0147-2. View

Faria J, Vegi P, Miguita A, Dos Santos M, Boechat N, Bernardino A . Recently reported biological activities of pyrazole compounds. Bioorg Med Chem. 2017; 25(21):5891-5903. DOI: 10.1016/j.bmc.2017.09.035. View

de Oliveira L, Bueno da Silva D, Florentino I, Fajemiroye J, de Oliveira T, Marcelino R . New pyrazole derivative 5-[1-(4-fluorophenyl)-1H-pyrazol-4-yl]-2H-tetrazole: synthesis and assessment of some biological activities. Chem Biol Drug Des. 2016; 89(1):124-135. DOI: 10.1111/cbdd.12838. View

Galvao G, Florentino I, Sanz G, Vaz B, Liao L, Sabino J . Anti-inflammatory and antinociceptive activity profile of a new lead compound - LQFM219. Int Immunopharmacol. 2020; 88:106893. DOI: 10.1016/j.intimp.2020.106893. View

Al-Omar M . Synthesis and antimicrobial activity of new 5-(2-thienyl)-1,2,4-triazoles and 5-(2-thienyl)-1,3,4-oxadiazoles and related derivatives. Molecules. 2010; 15(1):502-14. PMC: 6257108. DOI: 10.3390/molecules15010502. View

10.

Basu S, Barawkar D, Ramdas V, Patel M, Waman Y, Panmand A . Design and synthesis of novel xanthine derivatives as potent and selective A adenosine receptor antagonists for the treatment of chronic inflammatory airway diseases. Eur J Med Chem. 2017; 134:218-229. DOI: 10.1016/j.ejmech.2017.04.014. View

11.

Ikeda M, Maruyama K, Nobuhara Y, Yamada T, Okabe S . Synthesis and cytoprotective antiulcer activity of 2- or 4-(1H-pyrazol-1-yl)pyrimidine derivatives related to mepirizole and dulcerozine. Chem Pharm Bull (Tokyo). 1996; 44(9):1700-6. DOI: 10.1248/cpb.44.1700. View

12.

Fadaly W, Elshaier Y, Hassanein E, Abdellatif K . New 1,2,4-triazole/pyrazole hybrids linked to oxime moiety as nitric oxide donor celecoxib analogs: Synthesis, cyclooxygenase inhibition anti-inflammatory, ulcerogenicity, anti-proliferative activities, apoptosis, molecular modeling and nitric oxide.... Bioorg Chem. 2020; 98:103752. DOI: 10.1016/j.bioorg.2020.103752. View

13.

Hill B, Whelan R . Antitumour activity and cell kinetic effects of pyrazofurin in vitro. Eur J Cancer (1965). 1980; 16(12):1633-8. DOI: 10.1016/0014-2964(80)90039-0. View

14.

Hrelia P, Sita G, Ziche M, Ristori E, Marino A, Cordaro M . Common Protective Strategies in Neurodegenerative Disease: Focusing on Risk Factors to Target the Cellular Redox System. Oxid Med Cell Longev. 2020; 2020:8363245. PMC: 7422410. DOI: 10.1155/2020/8363245. View

15.

Benek O, Korabecny J, Soukup O . A Perspective on Multi-target Drugs for Alzheimer's Disease. Trends Pharmacol Sci. 2020; 41(7):434-445. DOI: 10.1016/j.tips.2020.04.008. View

16.

Girodet P, Ozier A, Carvalho G, Ilina O, Ousova O, Gadeau A . Ca(2+)-activated K(+) channel-3.1 blocker TRAM-34 attenuates airway remodeling and eosinophilia in a murine asthma model. Am J Respir Cell Mol Biol. 2012; 48(2):212-9. PMC: 4035224. DOI: 10.1165/rcmb.2012-0103OC. View

17.

Oliveira D, Sousa F, Birmann P, Alves D, Jacob R, Savegnago L . Antinociceptive and anti-inflammatory effects of 4-(arylchalcogenyl)-1H-pyrazoles containing selenium or sulfur. Pharmacol Rep. 2020; 72(1):36-46. DOI: 10.1007/s43440-019-00001-4. View

18.

Ozdemir Z, Alagoz M, Uslu H, Karakurt A, Erikci A, Ucar G . Synthesis, molecular modelling and biological activity of some pyridazinone derivatives as selective human monoamine oxidase-B inhibitors. Pharmacol Rep. 2020; 72(3):692-704. DOI: 10.1007/s43440-020-00070-w. View

19.

Mohd Faudzi S, Leong S, Auwal F, Abas F, Wai L, Ahmad S . In silico studies, nitric oxide, and cholinesterases inhibition activities of pyrazole and pyrazoline analogs of diarylpentanoids. Arch Pharm (Weinheim). 2020; 354(1):e2000161. DOI: 10.1002/ardp.202000161. View

20.

Abdellatif K, Abdelall E, Lamie P, Labib M, El-Nahaas E, Abdelhakeem M . New pyrazole derivatives possessing amino/methanesulphonyl pharmacophore with good gastric safety profile: Design, synthesis, cyclooxygenase inhibition, anti-inflammatory activity and histopathological studies. Bioorg Chem. 2020; 95:103540. DOI: 10.1016/j.bioorg.2019.103540. View